COO Cooper Companies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: COO

Price (delayed)

$53.91

Market cap

$10.25B

P/E Ratio

18.34

Dividend/share

N/A

EPS

$2.94

Enterprise value

$12.64B

?
Relative Growth: Rel. Growth: 81
Relative Strength: Rel. Strength: 14
Relative Valuation: Rel. Valuation: 73
Relative Profitability: Rel. Profitability: 67

The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective ...

Highlights
COO's EPS has surged by 147% since the previous quarter and by 44% year-on-year
The company's net income has surged by 142% QoQ and by 40% YoY
The company's quick ratio fell by 44% YoY and by 3.8% QoQ
Cooper Companies's debt has increased by 3.4% from the previous quarter and by 2.7% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.coopercos.com
Peers: BSX TFX UTMD NVS

Key stats

What are the main financial stats of COO

COO stock price

How has the Cooper Companies stock price performed over time
Intraday
-0.48%
1 week
-22.53%
1 month
-29.82%
1 year
-21.25%
YTD
-34.22%
QTD
-24.82%

Financial performance

How have Cooper Companies's revenue and profit performed over time
Revenue
$4.24B
Gross profit
$2.79B
Operating income
$527.8M
Net income
$570.3M
Gross margin
65.9%
Net margin
13.5%
The company's net income has surged by 142% QoQ and by 40% YoY
Cooper Companies's net margin has soared by 141% from the previous quarter and by 34% YoY
The operating margin has decreased by 31% YoY but it has increased by 10% QoQ
The company's operating income fell by 28% YoY but it rose by 10% QoQ

Price vs fundamentals

How does COO's price correlate with its fundamentals

Growth

What is Cooper Companies's growth rate over time

Valuation

What is Cooper Companies stock price valuation
COO P/E details
P/E
18.34
P/B
1.26
P/S
2.46
EV/EBIT
22.92
EV/EBITDA
12.88
EV/Sales
2.98
COO's EPS has surged by 147% since the previous quarter and by 44% year-on-year
The stock's price to earnings (P/E) is 57% less than its 5-year quarterly average of 42.5 and 53% less than its last 4 quarters average of 38.7
COO's P/B is 43% below its 5-year quarterly average of 2.2 and 26% below its last 4 quarters average of 1.7
The price to sales (P/S) is 48% lower than the 5-year quarterly average of 4.7 and 28% lower than the last 4 quarters average of 3.4
The company's revenue rose by 4.7% YoY

Efficiency

How efficient is Cooper Companies business performance
The company's return on equity has surged by 146% QoQ and by 38% YoY
Cooper Companies's ROA has soared by 142% from the previous quarter and by 39% YoY
COO's return on sales is down by 27% year-on-year but it is up by 9% since the previous quarter
COO's return on invested capital is down by 20% year-on-year but it is up by 9% since the previous quarter

Dividends

What is COO's dividend history
Dividend details
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Cooper Companies financials performed over time
Cooper Companies's total assets is 192% more than its total liabilities
The company's quick ratio fell by 44% YoY and by 3.8% QoQ
The current ratio has decreased by 42% YoY and by 3.9% from the previous quarter
Cooper Companies's debt is 69% less than its equity
Cooper Companies's debt has increased by 3.4% from the previous quarter and by 2.7% YoY
Cooper Companies's debt to equity has increased by 3.3% QoQ and by 3.3% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.